Molinate Chemical Review

In May 2003, the APVMA began a review of molinate because of toxicological, occupational health and safety and environmental concerns.

As part of the nomination the APVMA released the Molinate review scope document. This scope document outlines the information needed to conduct a comprehensive scientific assessment of molinate.

In June 2004, the Advisory Committee on Chemicals Scheduling reconsidered the scheduling of molinate. The committee included molinate in Schedule 7 of the Standard for the Uniform Scheduling of Medicines and Poisons.

In June 2011, registrants voluntarily amended product labels in a collaborative effort with the APVMA to reduce worker exposure to molinate. Molinate product labels were amended to read ‘For use in closed delivery and supply systems only’.

In June 2013, the APVMA released the toxicological and occupational health and safety assessments for molinate in combination with a targeted consultation with affected industry and state departmental agencies. These assessments did not support the ongoing ground or aerial application of molinate, based on human health concerns.

In January 2014 the APVMA released the Molinate preliminary review findings report. This proposed the cancellation of all active constituent approvals, all product registrations and all product label approvals on the basis that products containing molinate may have an effect that is harmful to humans and compromise worker safety.

The APVMA invited comment on the Molinate Preliminary Review Findings Report from 13 January 2014 to 6 April 2014. Four submissions were received during this period.